Meitar represented Singapore Telecom, Southeast Asia’s largest telecom company, in its acquisition of Amobee, a mobile advertising company, for approximately $320 million in cash. The transaction is expected to be completed during the second quarter of 2012.
Meitar acted as local counsel for Cisco in its intended acquisition of NDS Group, a leading provider of video software and content security solutions for approximately $5 billion. The transaction is expected to be completed during the second half of 2012.
Meitar represented Objet, an Israel-based manufacturer of 3D printers, in a contemplated IPO on NASDAQ, which in its advanced stages was deferred, in a dual-tracking process, in favor of entering into an all-stock merger of equals with Stratasys, a Delaware corporation (NASDAQ:SSYS). Under this innovative structure, the shares of the publicly traded Stratasys will be exchanged for shares in the currently privately-held Objet. At closing, Objet will simultaneously become the parent company of the merged entities and, for the first time, a publicly traded company on NASDAQ.
Meitar represented Covidien, a U.S. medical device manufacturer, in its acquisition of Oridion Systems Ltd., an Israeli company and a global leader in capnography monitoring, for $346 million in cash. The transaction is expected to be completed during the second quarter of 2012.
Meitar represented Broadlight a provider of highly integrated networking and fiber access PON (Passive Optical Network) processors in its acquisition by Broadcom Corporation a global leader in semiconductor solutions for wired and wireless communications for approximately $220 million. The transaction was completed on April 5, 2012.
Our firm, together with US-based Fenwick & West LLP, represented Facebook, Inc. (NASDAQ: FB) in the acquisition of Face.com, the developer of a leading face-recognition technology. Financial terms of the transaction were not disclosed.
Meitar represented privately-held Surpass Medical Ltd., a developer of next-generation flow diversion stent technology to treat brain aneurysms using a unique mesh design and delivery system in its acquisition by Stryker Corporation for up to $135 million, in an all cash transaction.
